Pasithea Therapeutics

KTTANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$17.055 M

$0.51 -2.54%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$20.4M

Loss-making

Shares outstanding

33,414,448

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Pasithea Therapeutics lists more than one class of stock. Company figures above cover all classes combined.

KTTAW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#405BiofronteraBFRI$17.2M
#406NewcelXNCEL$17.2M
#407Pasithea TherapeuticsKTTA$17.1M
#408Lisata TherapeuticsLSTA$16.9M
#409Dare BioscienceDARE$15.9M

What if Pasithea Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$906,016.90

Per share 1,775,111× higher

Bitcoin $1.72T

$51,468.87

Per share 100,840× higher

Nvidia $5.48T

$163,996.67

Per share 321,310× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Pasithea Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.